Phase III randomised trialDouble blind randomized prospective trial of bethanechol (cas 111244-96-3) in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients
-
Add time:08/29/2019 Source:sciencedirect.com
This study assessed the prophylactic bethanechol (cas 111244-96-3) use to prevent salivary gland dysfunction during radiotherapy. A total of 97 head and neck cancer patients were allocated into two groups: Bethanechol or Placebo. Bethanechol group presented significantly improve of salivary parameters. Bethanechol was effective in decreasing the salivary gland damage.
We also recommend Trading Suppliers and Manufacturers of bethanechol (cas 111244-96-3). Pls Click Website Link as below: cas 111244-96-3 suppliers
Prev:Toxicological and metabolic investigations of the safety of N-α-Lauroyl-l-arginine ethyl ester monohydrochloride (LAE)
Next:Bioengineering/NanomedicineIn vitro Effect of bethanechol (cas 111244-96-3) and Suberyldicholine on Regions of Guinea Pig Esophagus) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- In vitro effects of bethanechol (cas 111244-96-3) on smooth muscle preparations from abomasal fundus, corpus, and antrum of dairy cows09/04/2019
- Short communicationAn adult case of cerebral malakoplakia successfully cured by treatment with antibiotics, bethanechol (cas 111244-96-3) and ascorbic acid09/03/2019
- bethanechol (cas 111244-96-3)-induced responses in mudpuppy parasympathetic neurons09/02/2019
- INVESTIGATIVE UROLOGYELECTROMOTIVE ADMINISTRATION OF INTRAVESICAL bethanechol (cas 111244-96-3) AND THE CLINICAL IMPACT ON ACONTRACTILE DETRUSOR MANAGEMENT:: INTRODUCTION OF A NEW TEST09/01/2019
- Liver, Pancreas and Biliary Tractbethanechol (cas 111244-96-3) provocation testing does not predict symptom relief after cholecystectomy for acalculous biliary pain08/31/2019
- Bioengineering/NanomedicineIn vitro Effect of bethanechol (cas 111244-96-3) and Suberyldicholine on Regions of Guinea Pig Esophagus08/30/2019
